Starodub

Starodub

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Starodub is a specialized regulatory and quality consulting firm serving the life sciences sector from its base in Amsterdam. With a team of approximately 20 employees and a network of experts, it provides end-to-end support for drug and device development, from strategic planning and agency interactions to submission publishing and lean operational improvements. The company operates as a trusted partner for biotechs and pharma companies, aiming to bridge the gap between regulatory requirements and commercial objectives. Its service-based model is validated by client testimonials, particularly in advanced therapy areas like ATMPs.

Medical Devices

Technology Platform

Integrated regulatory, quality, and operational improvement consultancy services leveraging expertise in EMA/FDA/ICH guidelines, GMP, Lean methodologies, and a network of specialized experts.

Opportunities

Growing regulatory complexity for advanced therapies (ATMPs) and medical devices (EU MDR) drives demand for niche expertise.
The trend of small-to-mid-sized biotechs outsourcing regulatory functions provides a expanding client base.
Leveraging its Amsterdam location to serve as a hub for European biotech missions and partnerships.

Risk Factors

Revenue is dependent on the project-based biotech funding cycle, which can be volatile.
High competition from both large global CROs and small boutique consultancies.
Reliance on key personnel and founder for reputation and client relationships.

Competitive Landscape

Operates in a fragmented market competing with large full-service CROs (e.g., IQVIA, Parexel) that offer regulatory consulting, and numerous small boutique firms and independent consultants. Differentiates through a combined focus on strategic regulatory affairs and hands-on operational/quality improvement, with specific cited expertise in complex areas like CAR-T therapy development.